Live Updates

15

Apr 2026
Sterling softens as the Dollar strengthens; GBP/USD pauses near 1.3560 in Asia amid Middle East diplomacy hopes

GBP/USD snapped seven-day rally near 1.3560 as firmer dollar, softer inflation, UK yields slipped.

15

Apr 2026
Amid Iran optimism, USD/CAD edges above 1.3700 near 1.3780 in Europe, though direction stays uncertain

USD/CAD edged up near 1.3780 as risk-on mood followed reports of potential permanent US-Iran ceasefire.

15

Apr 2026
Silver retreats from a near-monthly high, yet remains bullish around $80, failing to sustain gains above $81

Silver pulled back from a one-month high near $81, holding $80; bullish indicators, key Fibonacci levels.

15

Apr 2026
Optimism over potential US–Iran talks lifts sentiment, supporting the Australian Dollar and pushing AUD/USD to 0.7120

AUD/USD extended gains near 0.7120 as risk sentiment improved on US-Iran talk prospects and softer US PPI.

15

Apr 2026
South Korea’s trade surplus rises to $26.23B, improving from $25.74B in March

South Korea’s trade balance increased to $26.23bn in March, up $0.49bn from the previous period.

15

Apr 2026
WTI hovers near $87.50, falling for a second day, as Trump hints at renewed Iran talks

WTI slips near $87.50 as US–Iran talks loom, Hormuz risks persist, and US crude inventories jump.

15

Apr 2026
US Vice President Vance said US-Iran negotiations continue, seeking a broader deal to improve Iran’s global integration

Vance says US-Iran talks progressing via multiple channels; broader economic deal eyed; ceasefire holds; nuclear weapons ruled out.

15

Apr 2026
China’s central bank fixed USD/CNY at 6.8582, versus 6.8593 prior and 6.8096 Reuters forecast

PBOC set USD/CNY fix at 6.8582, slightly stronger than prior, as it manages stability, reforms, rates.

15

Apr 2026
EUR/USD hovers near 1.1790, steady after seven rising sessions, as US-Iran talks boost optimism Asia-hours Wednesday

EUR/USD steadied near 1.1790 as weaker dollar, Iran-talk hopes and softer PPI lifted euro too.

15

Apr 2026
Cencora grows steadily despite thin margins, avoiding flashiness or dramatic narratives, and rarely commands investor attention

Cencora, major US drug distributor, grew revenue to $321B; Walgreens deal, OneOncology acquisition, raised outlook amid bearish bias.

Back To Top
server

Hello there 👋

How can I help you?

We're here to help

Chat with us

Start a live conversation through...

  • Telegram
    hold On hold
  • Coming Soon...

Hello there 👋

How can I help you?

telegram

Scan the QR code with your smartphone to start a chat with us, or click here.

Don’t have the Telegram App or Desktop installed? Use Web Telegram instead.

QR code